Literature DB >> 16261113

Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration.

Daisuke Sakai1, Joji Mochida, Toru Iwashina, Takuya Watanabe, Tomoko Nakai, Kiyoshi Ando, Tomomitsu Hotta.   

Abstract

STUDY
DESIGN: An in vivo study to assess the differentiation status of mesenchymal stem cells (MSCs) transplanted to the nucleus pulposus of degenerative discs in a rabbit model.
OBJECTIVES: To evaluate the fate of MSCs transplanted to the nucleus pulposus of degenerative discs in a rabbit and to determine whether they are a suitable alternative for cell transplantation therapy for disc degeneration. SUMMARY OF BACKGROUND DATA: Although MSCs have been proposed as candidate donor cells for transplantation to treat intervertebral disc degeneration, their differentiation after transplantation has not been adequately investigated.
METHODS: Autologous MSCs, labeled with green fluorescent protein, were transplanted into mature rabbits. Consecutive counts of transplanted MSCs in the nucleus area were performed for 48 weeks after transplantation. Differentiation of transplanted cells was determined by immunohistochemical analysis. The proteoglycan content of discs was measured quantitatively using a dimethylmethylene blue assay, and mRNA expression of Type I and II collagen, aggrecan and versican was measured semi-quantitatively using reverse transcription polymerase chain reaction.
RESULTS: Many cells that were positive for green fluorescent protein were observed in the nucleus pulposus of cell-transplanted rabbit discs 2 weeks after transplantation. Their number increased significantly by 48 weeks. Some GFP-positive cells were positive for cell-associated matrix molecules, such as Type II collagen, keratan sulfate, chondroitin sulfate, aggrecan, and the nucleus pulposus phenotypic markers, hypoxia inducible factor 1 alpha, glutamine transporter 1, and matrix metalloproteinase 2. MSCs did not show significant expression of these molecules before transplantation. Biochemical and gene expression analyses showed significant restoration of total proteoglycan content and matrix-related genes compared with nontransplanted discs.
CONCLUSIONS: MSCs transplanted to degenerative discs in rabbits proliferated and differentiated into cells expressing some of the major phenotypic characteristics of nucleus pulposus cells, suggesting that these MSCs may have undergone site-dependent differentiation. Further studies are needed to evaluate their functional role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16261113     DOI: 10.1097/01.brs.0000184365.28481.e3

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  119 in total

1.  Structured coculture of mesenchymal stem cells and disc cells enhances differentiation and proliferation.

Authors:  Aliza A Allon; Kristin Butcher; Richard A Schneider; Jeffrey C Lotz
Journal:  Cells Tissues Organs       Date:  2012-03-01       Impact factor: 2.481

2.  Transplantation of goat bone marrow stromal cells to the degenerating intervertebral disc in a goat disc injury model.

Authors:  Yejia Zhang; Susan Drapeau; S An Howard; Eugene J M A Thonar; D Greg Anderson
Journal:  Spine (Phila Pa 1976)       Date:  2011-03-01       Impact factor: 3.468

Review 3.  Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction.

Authors:  Victor Y L Leung; Danny Chan; Kenneth M C Cheung
Journal:  Eur Spine J       Date:  2006-07-15       Impact factor: 3.134

4.  The fabrication of cryogel scaffolds incorporated with poloxamer 407 for potential use in the regeneration of the nucleus pulposus.

Authors:  Nicholas A Temofeew; Katherine R Hixon; Sarah H McBride-Gagyi; Scott A Sell
Journal:  J Mater Sci Mater Med       Date:  2017-01-31       Impact factor: 3.896

5.  Structured coculture of stem cells and disc cells prevent disc degeneration in a rat model.

Authors:  Aliza A Allon; Nicolas Aurouer; Bryan B Yoo; Ellen C Liebenberg; Zorica Buser; Jeffrey C Lotz
Journal:  Spine J       Date:  2010-10-25       Impact factor: 4.166

6.  Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints.

Authors:  Jaewoo Pak; Jae-Jin Chang; Jung Hun Lee; Sang Hee Lee
Journal:  BMC Musculoskelet Disord       Date:  2013-12-01       Impact factor: 2.362

7.  Injection of human umbilical tissue-derived cells into the nucleus pulposus alters the course of intervertebral disc degeneration in vivo.

Authors:  Steven K Leckie; Gwendolyn A Sowa; Bernard P Bechara; Robert A Hartman; Joao Paulo Coelho; William T Witt; Qing D Dong; Brent W Bowman; Kevin M Bell; Nam V Vo; Brian C Kramer; James D Kang
Journal:  Spine J       Date:  2013-02-04       Impact factor: 4.166

Review 8.  Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy.

Authors:  Benjamin Gantenbein; Svenja Illien-Jünger; Samantha C W Chan; Jochen Walser; Lisbet Haglund; Stephen J Ferguson; James C Iatridis; Sibylle Grad
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

9.  Sustained long-term RNA interference in nucleus pulposus cells in vivo mediated by unmodified small interfering RNA.

Authors:  Teppei Suzuki; Kotaro Nishida; Kenichiro Kakutani; Koichiro Maeno; Takashi Yurube; Toru Takada; Masahiro Kurosaka; Minoru Doita
Journal:  Eur Spine J       Date:  2009-01-14       Impact factor: 3.134

Review 10.  Cell therapy for intervertebral disc repair: advancing cell therapy from bench to clinics.

Authors:  L M Benneker; G Andersson; J C Iatridis; D Sakai; R Härtl; K Ito; S Grad
Journal:  Eur Cell Mater       Date:  2014-05-06       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.